H. B. Fuller (NYSE:FUL) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of H. B. Fuller (NYSE:FUL) from a hold rating to a buy rating in a research note issued to investors on Saturday morning.

A number of other research analysts also recently issued reports on FUL. JPMorgan Chase & Co. raised their price target on H. B. Fuller from $50.00 to $54.00 and gave the stock an “underweight” rating in a research note on Friday, June 27th. Seaport Res Ptn raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of H. B. Fuller in a research report on Tuesday, October 14th. Robert W. Baird increased their price objective on H. B. Fuller from $60.00 to $75.00 and gave the stock an “outperform” rating in a research report on Friday, June 27th. Finally, Citigroup upgraded H. B. Fuller from a “neutral” rating to a “buy” rating and upped their price target for the stock from $62.00 to $70.00 in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $67.75.

H. B. Fuller Stock Down 2.3%

Shares of NYSE FUL opened at $60.08 on Friday. The company has a market capitalization of $3.25 billion, a price-to-earnings ratio of 32.48, a price-to-earnings-growth ratio of 1.11 and a beta of 1.12. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.93 and a quick ratio of 1.18. The business has a 50-day moving average of $60.14 and a two-hundred day moving average of $58.05. H. B. Fuller has a 1 year low of $47.56 and a 1 year high of $80.15.

H. B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 earnings per share for the quarter. The business had revenue of $725.90 million for the quarter. H. B. Fuller had a return on equity of 11.49% and a net margin of 3.28%. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. On average, analysts forecast that H. B. Fuller will post 4.07 earnings per share for the current fiscal year.

H. B. Fuller Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 30th. Stockholders of record on Thursday, October 16th will be paid a dividend of $0.235 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, October 16th. H. B. Fuller’s dividend payout ratio is 50.81%.

Insider Activity

In related news, VP Joao Magalhaes sold 1,099 shares of the company’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $56.31, for a total transaction of $61,884.69. Following the transaction, the vice president owned 3,285 shares of the company’s stock, valued at $184,978.35. This represents a 25.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.99% of the company’s stock.

Institutional Investors Weigh In On H. B. Fuller

Institutional investors have recently made changes to their positions in the stock. Salomon & Ludwin LLC purchased a new stake in shares of H. B. Fuller during the 3rd quarter worth $28,000. Parallel Advisors LLC lifted its stake in shares of H. B. Fuller by 141.6% in the second quarter. Parallel Advisors LLC now owns 534 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 313 shares during the period. AdvisorNet Financial Inc lifted its stake in shares of H. B. Fuller by 160.8% in the third quarter. AdvisorNet Financial Inc now owns 845 shares of the specialty chemicals company’s stock valued at $50,000 after purchasing an additional 521 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of H. B. Fuller by 129.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock valued at $73,000 after purchasing an additional 688 shares during the period. Finally, Smartleaf Asset Management LLC increased its holdings in H. B. Fuller by 44.4% in the second quarter. Smartleaf Asset Management LLC now owns 1,307 shares of the specialty chemicals company’s stock valued at $81,000 after buying an additional 402 shares in the last quarter. 95.93% of the stock is currently owned by hedge funds and other institutional investors.

About H. B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.